|
|
|
Volumn 19, Issue 6, 2005, Pages 42-43
|
|
Malaria, science, and social responsibility
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMALARIAL AGENT;
ANTIVIRUS AGENT;
ARTEMETHER PLUS BENFLUMETOL;
ARTEMISININ;
PACLITAXEL;
PROSTRATIN;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BACTERIUM;
BIOTECHNOLOGY;
CLINICAL TRIAL;
DEVELOPING COUNTRY;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SYNTHESIS;
DRUG TARGETING;
ECONOMIC ASPECT;
ESCHERICHIA COLI;
GENETIC ENGINEERING;
GENOME;
HEALTH CARE COST;
HEALTH CARE NEED;
HEALTH CARE ORGANIZATION;
HUMAN;
MALARIA;
PATENT;
PLASMODIUM FALCIPARUM;
PROFIT;
SCIENCE;
SHORT SURVEY;
SOCIAL ASPECT;
STANDARD;
TECHNIQUE;
BACTERIA (MICROORGANISMS);
ESCHERICHIA COLI;
PLASMODIUM FALCIPARUM;
|
|
EID: 17644399488
PISSN: 08903670
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (8)
|
|
References (0)
|
